Skip to main content
. 2019 Nov 5;10(60):6466–6483. doi: 10.18632/oncotarget.27294

Table 3. Differentially expressed genes in prostate tissue specimens of patients with or without progression to BCR based on expression in tumor only and ratio of expression in tumor vs. normal.

Tumor only Tumor vs Normal
Probe p value q-value Expected FP BCR vs Non-BCR Probe p value q-value Expected FP BCR vs Non-BCR
1 ERG8 3.50E-05 0.00287 0.003 Pan.ERG 0.00025 0.01594 0.016
2 ERG1.ERG2.ERG3 0.00012 0.00505 0.010 ERG8 0.00036 0.01594 0.032
3 Pan.ERG 0.00036 0.00951 0.029 ERG1.ERG2.ERG3 0.00124 0.03686 0.111
4 GGT1 0.00046 0.00951 0.038 T2. ERG.exon4.fusion 0.00342 0.06245 0.250
5 HDAC1 0.00158 0.02542 0.127 TP53 0.00349 0.06245 0.312
6 KLK2 0.00197 0.02542 0.153 HDAC1 0.00575 0.08562 0.514
7 MYO6 0.00214 0.02542 0.178 NCOA2 0.01971 0.24723 1.731
8 PLA2G7 0.00283 0.02941 0.235 VEGFA 0.02213 0.24723 1.978
9 T2.ERG.exon4.fusion 0.00319 0.02947 0.265 PTEN 0.03389 0.30341 2.731
10 BICD1 0.00509 0.04225 0.422 ACPP 0.03911 0.30341 3.034
11 CACNA1D 0.00993 0.07502 0.825 KLF4 0.04010 0.30341 3.337
12 ACPP 0.02298 0.15908 1.909 TMPRSS2 0.04074 0.30341 3.641
13 FAS 0.03467 0.22155 2.880 FAS 0.04674 0.32132 4.177
14 T2.ERG.exon2.fusion 0.03828 0.22718 3.180 HSP27 0.06458 0.39413 5.518
15 C.MYC 0.06511 0.34971 5.246 T2.ERG.exon2.fusion 0.06616 0.39413 5.912